Provider directories for Medicare Advantage and AI prior authorization in select states are among the changes for 2026.

The 2026 Part D plans became available to the public Oct. 1 at Medicare.gov, and there are serious changes, with Part D ...

Cambridge Health Alliance is “deeply concerned” about proposed changes to a prescription drug discount program that has ...

Bayer remains undervalued despite litigation and weak results, with upside if turnaround succeeds and FCF normalizes. Find ...

The atrial fibrillation (AF) market across the eight major markets (8MM) is forecast to decline at a negative compound annual ...

Lupin share price fell 1 percent in the opening trade on October 6 following the company received four observations to its Pithampur unit from USFDA. At 09:25 hrs Lupin was quoting at Rs 1,952.35, ...

JNJ's Innovative Medicine sales face biosimilar pressure and IRA headwinds, but growth drivers like Darzalex, Tremfya and Erleada may have ensured steady Q3 momentum.

Late last month, Pfizer PFE announced a landmark deal with the Trump administration to cut drug prices and expand U.S.

Johnson & Johnson JNJ will begin the earnings season for the drug & biotech sector when it reports its third-quarter 2025 ...

Learn the critical factors in determining prophylaxis for venous thromboembolism, a frequent and serious complication for ...

Newsroom is open 24 hours, please reach us by email at [email protected] or by phone Monday through Friday 9-5. You can place DBA (Fictitious Business Name Statement) orders online by clicking on t ...

Bayer and Kumquat launch a phase I study of KQB548, aiming to target various KRAS G12D-mutated tumors like pancreatic, ...